<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Lu F</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Primary Membranous Nephropathy (PMN) is characterized by dysregulated immune responses, with B cells playing critical roles in disease pathogenesis. However, the immunopathogenic mechanisms underlying B cell involvement in PMN remain elusive.&lt;h4>Methods&lt;/h4>We employed single-cell RNA sequencing on peripheral blood mononuclear cell samples (PBMC) obtained from 6 patients with PMN and 3 healthy controls (NC) to explore the transformation of B cells and their interaction with immune cells.&lt;h4>Results&lt;/h4>Compared with NC, the most significant alterations were in plasma cells and regulatory B (Breg) cells in PMN patients. Within plasma cells, Subcluster 0 was increased in PMN patients and exhibited enhanced autoimmunity. Breg subset B10 cells were elevated in PMN patients and displayed increased immune regulatory capacity, marked by enhanced cytokine and interleukin-10 production. B cell activating factor (BAFF) and galectin-9, which were secreted by CD14 monocyte, as potential regulators of plasma and Breg cells activity. Additionally, serum galectin-9 levels increased in PMN patients and showed a correlation with proteinuria and renal function in PMN.&lt;h4>Conclusions&lt;/h4>We reveal novel insights into the heterogeneity and functional diversity of B cells in patients with PMN. And revealed distinct roles for subgroup 0 plasma cells and B10 Breg cells in the pathogenesis of PMN. Furthermore, targeting B cells, such as galectin-9, presents promising opportunities for modulating the immune response in patients with PMN.</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>1622395</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12401916</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Exploring immunological alterations of B cells in peripheral immunity via single-cell RNA sequencing: insights into primary membranous nephropathy.</pubmed_title><pmcid>PMC12401916</pmcid><pubmed_authors>Wu L</pubmed_authors><pubmed_authors>Pan Y</pubmed_authors><pubmed_authors>Xing C</pubmed_authors><pubmed_authors>Mao H</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Shu H</pubmed_authors><pubmed_authors>Lu F</pubmed_authors><pubmed_authors>Liu S</pubmed_authors><pubmed_authors>Liang H</pubmed_authors><pubmed_authors>Guo H</pubmed_authors><pubmed_authors>Duan S</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors><pubmed_authors>Yuan Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Exploring immunological alterations of B cells in peripheral immunity via single-cell RNA sequencing: insights into primary membranous nephropathy.</name><description>&lt;h4>Background&lt;/h4>Primary Membranous Nephropathy (PMN) is characterized by dysregulated immune responses, with B cells playing critical roles in disease pathogenesis. However, the immunopathogenic mechanisms underlying B cell involvement in PMN remain elusive.&lt;h4>Methods&lt;/h4>We employed single-cell RNA sequencing on peripheral blood mononuclear cell samples (PBMC) obtained from 6 patients with PMN and 3 healthy controls (NC) to explore the transformation of B cells and their interaction with immune cells.&lt;h4>Results&lt;/h4>Compared with NC, the most significant alterations were in plasma cells and regulatory B (Breg) cells in PMN patients. Within plasma cells, Subcluster 0 was increased in PMN patients and exhibited enhanced autoimmunity. Breg subset B10 cells were elevated in PMN patients and displayed increased immune regulatory capacity, marked by enhanced cytokine and interleukin-10 production. B cell activating factor (BAFF) and galectin-9, which were secreted by CD14 monocyte, as potential regulators of plasma and Breg cells activity. Additionally, serum galectin-9 levels increased in PMN patients and showed a correlation with proteinuria and renal function in PMN.&lt;h4>Conclusions&lt;/h4>We reveal novel insights into the heterogeneity and functional diversity of B cells in patients with PMN. And revealed distinct roles for subgroup 0 plasma cells and B10 Breg cells in the pathogenesis of PMN. Furthermore, targeting B cells, such as galectin-9, presents promising opportunities for modulating the immune response in patients with PMN.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-04-08T16:05:08.101Z</modification><creation>2026-04-08T06:02:36.694Z</creation></dates><accession>S-EPMC12401916</accession><cross_references><pubmed>40904455</pubmed><doi>10.3389/fimmu.2025.1622395</doi></cross_references></HashMap>